BSY-001
N/A
Report date: 2025/01/23 10:20:04
NME
Base Information
Drug NameBSY-001
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Beishengyan Pharmaceutical Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Beishengyan Pharmaceutical Technology Co LtdChina National Biotec Holding LtdBeijing Institute Of Biological Products Co Ltd +[4]
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A